Mereo BioPharma Group plc - ADR (MREO) is down Thursday morning, with the stock falling -3.63% in pre-market trading to 1.86. MREO's short-term technical score of 89 indicates that the stock has traded more bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, MREO ranks higher than 94% of stocks. Mereo BioPharma Group plc - ADR has risen 32.19% over the past month, closing at $1.33 on September 21. During this period of time, the stock fell as low as $1.19 and as high as $1.83. MREO has an average analyst recommendation of Strong Buy. The company has an average price target of $4.33.
MREO has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on MREO!